模型介绍
This model is a **state-of-the-art** fine-tuned transformer engineered to deliver **enterprise-grade accuracy** for chemical entity recognition - chemical entities from the bc5cdr dataset. This specialized model excels at identifying and extracting biomedical entities from clinical texts, research papers, and healthcare documents, enabling applications such as **drug interaction detection**, **medication extraction from patient records**, **adverse event monitoring**, **literature mining for drug discovery**, and **biomedical knowledge graph construction** with **production-ready reliability** for clinical and research applications. BC5CDR-Chem focuses on chemical entity recognition from the BioCreative V Chemical-Disease Relation extraction task. The BC5CDR-Chem corpus is part of the BioCreative V Chemical-Disease Relation (CDR) extraction challenge, specifically targeting chemical entity recognition in biomedical texts. This dataset contains 1,500 PubMed abstracts with 4,409 annotated chemical entities, designed to support automated drug discovery and pharmacovigilance applications. The corpus emphasizes chemical compounds, drugs, and therapeutic substances that are relevant for understanding chemical-disease relationships. It serves as a critical resource for developing NER systems that can identify chemical entities for downstream tasks like adverse drug reaction detection and drug repurposing research.
主要特点
特点摘要待依据来源补齐，不凭模型名称推断能力。
局限与注意事项
暂无足够来源支持具体缺点结论。请重点验证实际任务表现、时延、数据政策、许可与版本生命周期。
来源报价与费用分析
同一模型在不同渠道、地区和配置下可能采用不同价格。下表独立保留各渠道报价，不将渠道价格视为厂商官方统一价格。
| 来源 / 渠道 | 输入 | 输出 | 计费单位 | 采集时间 |
|---|---|---|---|---|
| 暂未取得可核验报价，请查阅来源渠道。 | ||||
按月估算基础 Token 费用
预估不包含缓存优惠、阶梯定价、多模态附加费用、网络检索、税费及推理额外输出。
公开评测与运行配置
暂无已采集的可核验公开评分。模型未上榜不代表能力较低。
查看完整已收录榜单 →常见问题
开放权重是否代表可以免费商用？
不一定。应核对具体版本许可证、商用门槛和使用政策。自部署还会产生算力和维护成本。
这些价格是实时结算价格吗？
不是实时结算价格，而是带采集时间的来源报价快照。请到对应渠道核对当前版本、区域、折扣和计费方式。
资料来源与可追溯记录
许可证：apache-2.0。模型介绍与第三方评测均以原来源的具体版本和方法为准。